Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

ORTX Orchard Therapeutics PLC

16,70

0,00 (0,00%)

Nach Börsenschluss

Zuletzt aktualisiert: 02:00:00

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Orchard Therapeutics (NASDAQ:ORTX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Orchard Therapeutics Charts.

Orchard Therapeutics (NASDAQ:ORTX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Orchard Therapeutics Charts.

News Orchard Therapeutics PLC

Orchard Therapeutics Announces Multiple Presentations at ASGCT 2024
Dienstag 7 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Orchard Therapeutics Co-founder and Chief Executive Officer Dr. Bobby Gaspar Named to Inaugural 2024 TIME100 Health List
Freitag 3 Mai 2024 (3 Wochen vor) • GlobeNewswire Inc.

Orchard Therapeutics Outlines U.S. Launch Plans for Lenmeldy™ (atidarsagene autotemcel), the Only Approved Therapy for Children with Early-onset Metachromatic Leukodystrophy
Mittwoch 20 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Orchard Therapeutics Receives FDA Approval of Lenmeldy™ (atidarsagene autotemcel), the Only Therapy for Eligible Children with Early-onset Metachromatic Leukodystrophy in the U.S.
Montag 18 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Donnerstag 15 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 15-12G - Securities registration termination [Section 12(g)]
Montag 5 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Orchard Therapeutics Announces First Patient Randomized in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome
Montag 5 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Orchard Therapeutics Announces Multiple Presentations at the 20th Annual WORLDSymposium
Freitag 2 Februar 2024 (4 Monate vor) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Mittwoch 31 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Orchard Therapeutics Announces Agreement with the Beneluxa Consortium Enabling Reimbursed Access to Libmeldy
Donnerstag 25 Januar 2024 (4 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 24 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 24 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere Orchard Therapeutics PLC News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen